These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15008361)

  • 21. [Sterol-fibrinogen blood complexes in patients with diabetes mellitus and associated ischemic heart disease].
    Bodnar PN; Donish RM; Buglak NI; Panasiukova OR
    Ter Arkh; 1983; 55(12):78-81. PubMed ID: 6665725
    [No Abstract]   [Full Text] [Related]  

  • 22. Cardiovascular prevention in patients with diabetes and prediabetes.
    Anselmino M; Gohlke H; Mellbin L; Rydén L
    Herz; 2008 Apr; 33(3):170-7. PubMed ID: 18568310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus.
    Jaumdally RJ; Lip GY; Patel JV; MacFadyen RJ; Varma C
    J Intern Med; 2009 Jun; 265(6):689-97. PubMed ID: 19226374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoprotein (a): role in diabetes and its vascular complications.
    Mohan A; Srinivasan V; Deepa R; Mohan V
    J Assoc Physicians India; 2001 Nov; 49():1100-5. PubMed ID: 11868866
    [No Abstract]   [Full Text] [Related]  

  • 25. C-reactive protein and risk factors for peripheral vascular disease in subjects with Type 2 diabetes mellitus.
    Yu HI; Sheu WH; Song YM; Liu HC; Lee WJ; Chen YT
    Diabet Med; 2004 Apr; 21(4):336-41. PubMed ID: 15049935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mechanism of coronary heart disease in diabetes].
    Ito H
    Nihon Rinsho; 2010 May; 68(5):772-5. PubMed ID: 20446568
    [No Abstract]   [Full Text] [Related]  

  • 27. Diabetes as a risk factor for coronary disease.
    Megarry S; Sapsford R; Hall A
    Practitioner; 1996 Jul; 240(1564):454-7. PubMed ID: 8801547
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pathogenesis and various clinical problems of cardiomyopathy in diabetes mellitus].
    Walasik L; Tatoń J
    Pol Tyg Lek; 1985 Mar; 40(10):317-22. PubMed ID: 3889882
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma levels of endothelin-1, angiotensin II, nitric oxide and prostaglandin E in the venous and cavernosal blood of patients with erectile dysfunction.
    El Melegy NT; Ali ME; Awad EM
    BJU Int; 2005 Nov; 96(7):1079-86. PubMed ID: 16225532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors influencing the epidemiology of and interrelations between atherosclerosis and diabetes mellitus.
    Pfeiffer EF
    Acta Diabetol Lat; 1971 Sep; 8 Suppl 1():425-8. PubMed ID: 5146915
    [No Abstract]   [Full Text] [Related]  

  • 31. Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces clinical inflammatory responses in type 2 diabetes with coronary artery disease after coronary angioplasty.
    Wang G; Wei J; Guan Y; Jin N; Mao J; Wang X
    Metabolism; 2005 May; 54(5):590-7. PubMed ID: 15877288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronary levels of angiotensin-II and endothelin-I in diabetic patients with and without coronary artery disease.
    Altieri PI; Marcial JM; Banchs HL; Escobales N; Crespo M; González W
    Bol Asoc Med P R; 2015; 107(1):5-7. PubMed ID: 26035976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diabetes and coronary heart disease frequently appear together. New guidelines regulate therapy and prevention].
    MMW Fortschr Med; 2006 Oct; 148(41):10-1. PubMed ID: 17190248
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of presence and extent of coronary narrowing in patients with left bundle branch block without diabetes mellitus to patients with and without left bundle branch block but with diabetes mellitus.
    Ozeke O; Aras D; Deveci B; Ozlu MF; Gurel OM; Canga A; Kaya V; Guler TE; Yildiz A; Ergun K; Selcuk MT; Topaloglu S; Maden O; Tufekcioglu O
    Am J Cardiol; 2006 Mar; 97(6):857-9. PubMed ID: 16516589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Significance of thrombocytes and plasma for the regulation of hemostasis in type II diabetics].
    Sinzinger H; Fitscha P
    Vasa; 1985; 14(2):121-4. PubMed ID: 4013489
    [No Abstract]   [Full Text] [Related]  

  • 36. Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension.
    Lim HS; Lip GY; Beevers DG; Blann AD
    Eur J Clin Invest; 2005 May; 35(5):324-9. PubMed ID: 15860044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythrocyte aggregation and erythrocyte membrane properties in type 2 diabetes mellitus and in vascular atherosclerotic disease.
    Caimi G; Canino B; Romano A; Catania A; Lo Presti R
    Thromb Haemost; 2000 Mar; 83(3):516-7. PubMed ID: 10744168
    [No Abstract]   [Full Text] [Related]  

  • 38. Triglyceride profile in dyslipidaemia of type 2 diabetes mellitus.
    Khan SR; Ayub N; Nawab S; Shamsi TS
    J Coll Physicians Surg Pak; 2008 May; 18(5):270-3. PubMed ID: 18541079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fenofibrate set to benefit from new research on its active metabolite, fenofibric acid.
    Cardiovasc J Afr; 2008; 19(3):171-2. PubMed ID: 18568186
    [No Abstract]   [Full Text] [Related]  

  • 40. Type 2 diabetes without the atherogenic metabolic triad does not predict angiographically assessed coronary artery disease in women.
    Blackburn P; Lemieux I; Lamarche B; Bergeron J; Perron P; Tremblay G; Gaudet D; Després JP
    Diabetes Care; 2008 Jan; 31(1):170-2. PubMed ID: 17934152
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.